Glofitamab in Relapsed/Refractory Diffuse Large B Cell Lymphoma: Real World Data

被引：6
|
作者：
Ferhanoglu, Burhan [1 ]
Gulbas, Zafer [2 ]
Uzay, Ant [3 ]
Ozcan, Muhit [4 ]
Ozkalemkas, Fahir [5 ]
Dal, Mehmet Sinan [6 ]
Kalyon, Hakan [7 ]
Akay, Olga Meltem [7 ]
Deveci, Burak [8 ]
Bekoz, Huseyin [9 ]
Sevindik, Omur Gokmen [9 ]
Toptas, Tayfur [10 ]
Yilmaz, Asu Fergun [10 ]
Koyun, Derya [11 ]
Alkis, Nihan [2 ]
Atesoglu, Elif Birtas [7 ]
机构：
[1] Koc Univ, Sch Med, Hematol Dept, Istanbul, Turkey
[2] Anadolu Med Ctr, Gebze, Turkey
[3] Acibadem Atakent Hosp, Hematol, Istanbul, Turkey
[4] Ankara Univ, Sch Med, Dept Hematol, Ankara, Turkey
[5] Uludag Univ, Hematol, Fac Med, Bursa, Turkey
[6] Ankara Oncol Hosp, Ankara, Turkey
[7] Koc Univ, Dept Internal Med, Div Hematol, Sch Med, Istanbul, Turkey
[8] Medstar Hosp, Antalya, Turkey
[9] Medipol Univ Hosp, Hematol, Istanbul, Turkey
[10] Marmara Univ Hosp, Hematol, Istanbul, Turkey
[11] Ankara Univ, Sch Med, Sch Med Dept Hematol, Ankara, Turkey
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-165385
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
627
引用
收藏
页码：6704 / 6705
页数：2
相关论文
共 50 条
  • [1] Glofitamab in relapsed/refractory diffuse large B-cell lymphoma: Real-world data
    Atesoglu, Elif Birtas
    Gulbas, Zafer
    Uzay, Ant
    Ozcan, Muhit
    Ozkalemkas, Fahir
    Dal, Mehmet Sinan
    Kalyon, Hakan
    Akay, Olga Meltem
    Deveci, Burak
    Bekoz, Huseyin
    Sevindik, Omur Gokmen
    Toptas, Tayfur
    Yilmaz, Fergun
    Koyun, Derya
    Alkis, Nihan
    Alacacioglu, Inci
    Sonmez, Mehmet
    Yavasoglu, Irfan
    Tombak, Anil
    Mehtap, Ozgur
    Kurnaz, Fatih
    Yuce, Orhan Kemal
    Karakus, Volkan
    Turgut, Mehmet
    Kurekci, Derya Deniz
    Ayer, Mesut
    Keklik, Muzaffer
    Buyuktas, Deram
    Ozbalak, Murat
    Ferhanoglu, Burhan
    [J]. HEMATOLOGICAL ONCOLOGY, 2023, 41 (04) : 663 - 673
  • [2] Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Dickinson, Michael J.
    Carlo-Stella, Carmelo
    Morschhauser, Franck
    Bachy, Emmanuel
    Corradini, Paolo
    Iacoboni, Gloria
    Khan, Cyrus
    Wrobel, Tomasz
    Offner, Fritz
    Wu, Shang-Ju
    Cartron, Guillaume
    Hertzberg, Mark
    Sureda, Anna
    Perez-Callejo, David
    Lundberg, Linda
    Relf, James
    Dixon, Mark
    Clark, Emma
    Humphrey, Kathryn
    Hutchings, Martin
    Trney, Marek
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (24): : 2220 - 2231
  • [3] Glofitamab in Relapsed Refractory Diffuse Large B-Cell Lymphoma: Single Center Experience
    Yaman, Samet
    Candir, Burcu Aslan
    Bozan, Ersin
    Dal, Mehmet Sinan
    Altuntas, Fevzi
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S445 - S445
  • [4] The Use of Glofitamab in Relapsed Diffuse Large B-Cell Lymphoma
    Falchi, Lorenzo
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2024, 22 (01) : 12 - 15
  • [5] Practice efficiency of treatment with epcoritamab versus glofitamab in relapsed/refractory diffuse large B-cell lymphoma
    Meyer, Kellie
    Huang, Danmeng
    O'Day, Ken
    Lahue, Betsy J.
    Wang, Anthony
    Mutebi, Alex
    Brodkin, Samantha
    Jun, Monika P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [6] Glofitamab combined with poseltinib and lenalidomide for relapsed/refractory diffuse large B cell lymphoma: Interim analysis of GPL study
    Koh, Youngil
    Byun, Ja Min
    Hong, Junshik
    Lim, Sung-nam
    Kim, Seok Jin
    Kong, Jee Hyun
    Lee, Gyeong-Won
    Kim, Hyo Jung
    Kim, Da Jung
    Lee, Jeong-Ok
    Park, Young-Hun
    Yoon, Dok Hyun
    Yoo, Kwai Han
    Kang, Hye Jin
    Yang, Deok-Hwan
    Kwak, Jae-Yong
    Kwon, Jung Hye
    Kang, Ka Won
    Baek, Dong Won
    Yoon, Sung-Soo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [7] Real-world outcomes with novel therapies in relapsed/refractory diffuse large B-cell lymphoma
    Crombie, Jennifer L.
    Jun, Monika
    Wang, Tongsheng
    Mutebi, Alex
    Wang, Anthony
    Chhibber, Anindit
    Kamalakar, Rajesh
    Ukropec, Jon
    Blaedel, Julie
    Kalsekar, Anupama
    [J]. LEUKEMIA & LYMPHOMA, 2024,
  • [8] Real World Characteristics and Outcomes of Patients with Relapsed and Refractory Diffuse Large B Cell Lymphoma; A Provincial Experience
    Manji, Farheen
    Stewart, Douglas A.
    [J]. BLOOD, 2020, 136
  • [9] Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    Friedberg, Jonathan W.
    [J]. HEMATOLOGY-AMERICAN SOCIETY HEMATOLOGY EDUCATION PROGRAM, 2011, : 498 - 505
  • [10] Blinatumomab in relapsed/refractory diffuse large B cell lymphoma
    Van Dijck, Ruben
    Janssens, Ann
    Dierickx, Daan
    Delforge, Michel
    Gheysens, Olivier
    Tousseyn, Thomas
    Verhoef, Gregor
    [J]. ANNALS OF HEMATOLOGY, 2017, 96 (10) : 1759 - 1762
12345